New York, NY — December 3, 2025 — Leads & Copy — Masimo (NASDAQ: MASI) revealed its long-term strategy at its 2025 Investor Day, which took place at the company’s headquarters. Masimo’s management presented updates on the company’s long-term strategy, including its patient monitoring leadership and multi-year pipeline.
The plan incorporates strategies for margin expansion, revenue growth, and increased cash flow. It also provided details regarding its growth pillars.
Masimo’s long-range plan through 2028 includes these financial targets:
- Revenue: Compound annual growth rate (CAGR) of 7%-10%
- Operating Margin: Approximately 30% by 2028
- Adjusted Earnings Per Share: $8.00 by 2028
- Operating Cash Flow: Approximately $1 billion cumulatively from 2026-2028
The company reaffirmed its 2025 financial guidance from November 4, including Non-GAAP Revenue of $1,510 – $1,530 million, Non-GAAP operating profit of $412 – $424 million, and Non-GAAP earnings per diluted share of $5.40 – $5.55.
Katie Szyman, Chief Executive Officer of Masimo, said Masimo’s market position is due to its innovations that empower clinicians and transform patient care. Szyman stated the company is well-positioned to advance its mission with its team, innovation, and execution plan. The company is committed to providing value to patients, shareholders, employees, and partners over the long term, she said.
A replay of the Masimo Investor Day webcast can be accessed here.
Masimo (NASDAQ: MASI) is a global medical technology company, which develops industry-leading monitoring technologies, including measurements, sensors, patient monitors, automation, and connectivity solutions. Masimo SET® Measure-through Motion and Low Perfusion™ pulse oximetry, introduced in 1995, has been shown to outperform other pulse oximetry technologies in over 100 independent and objective studies. Masimo SET® is estimated to be used on more than 200 million patients worldwide each year and is the primary pulse oximetry at all 10 top U.S. hospitals as ranked in the 2025 Newsweek World’s Best Hospitals listing. Additional information about Masimo and its products may be found at www.masimo.com/evidence/featured-studies/feature.
Contact:
Masimo
Source: Masimo
